Course

Demystifying the Diagnosis and Treatment of Inflammatory Eye Disease

Presented by: Alvin Wells, MD, PhD | We will take a close look at Inflammatory Eye Disease in this session. Join as we unpack the anatomy and how the eye is affected, treatment options, associated rheumatologic conditions, and how to handle refractory cases.

0 Lessons
Start Course

Course Summary

We will take a close look at Inflammatory Eye Disease in this session. Join as we unpack the anatomy and how the eye is affected, treatment options, associated rheumatologic conditions, and how to handle refractory cases.

To receive CNE credit, participants must complete the course, post-test, and conference evaluation. A certificate of completion will be automatically generated following the completion of the evaluation.

Faculty

Alvin Wells, MD, PhD
Aurora Rheumatology and Immunotherapy Center

Target Audience

The target audience for the forum includes registered nurses (RNs), nurse practitioners (NPs), physician assistants (PAs), and other healthcare professionals who are engaged in clinical practice, education, research, and advocacy for the care of adult and pediatric patients with rheumatic diseases.

Learning Objectives

1) Identify rheumatic conditions that have ocular involvement
2) Describe common rheumatic medications that have ocular side effects
3) Discuss complications from ocular inflammation
4) Review the current treatment approaches to inflammatory eye disease

Accreditation Statement

The Rheumatology Nurses Society is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).

Participants will receive 0.5 continuing nursing contact hours, including 0.5 pharmacotherapeutic hours, by actively participating in education sessions and completing an online evaluation upon completion of the program

Faculty Disclosures

According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Planners, reviewers, and faculty have disclosed no conflicts of interest related to the content of this education, with the exception of the following:

Alvin Wells, MD, PhD
Speakers Bureau: Abbvie, Amgen, BMS, Lilly, Novartis

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE contact hours for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately.

Supporters

This activity is supported by unrestricted educational grants from Abbvie, Novartis, Sandoz, Sanofi, Lilly USA, LLC, BMS, and Janssen.

Copyright Statement

© 2020. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).